tradingkey.logo
tradingkey.logo
Search

Cyclerion Therapeutics Inc

CYCN
Add to Watchlist
3.440USD
-0.060-1.71%
Close 07-31 16:00ETQuotes delayed by 15 min
14.59MMarket Cap
LossP/E TTM

CYCN Financials

See Cyclerion Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Cyclerion Therapeutics Inc Earnings Date

Latest Release
May 12, 2026
EPS / Forecast
-0.76/--
Revenue / Forecast
0.00/--
Period
FY2025 Earnings
Revenue(YoY)
2.07M
3.70%
EPS(YoY)
-1.11
8.65%
Analyst Rating
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-35.14%-0.76
-200.56%-0.21
-5.74%-0.30
79.97%-0.11
9.57%-0.56
130.22%0.21
-109.21%-0.29
71.25%-0.53
80.65%-0.62
79.22%-0.69
--3.11
---1.83
---3.20
---3.32
----
----
----
----
----
----
Revenue
-100.00%0.00
-43.24%1.02M
351.03%875.00K
--93.00K
--81.00K
--1.81M
--194.00K
----
----
--0.00
--0.00
----
----
-100.00%0.00
-100.00%0.00
-89.80%306.00K
1046.77%711.00K
300.75%533.00K
-13.00%348.00K
300.53%3.00M
Net Profit
-122.32%-3.18M
-250.75%-799.00K
-34.99%-976.00K
75.49%-324.00K
7.33%-1.43M
131.29%530.00K
-109.56%-723.00K
68.38%-1.32M
77.83%-1.54M
76.52%-1.69M
172.08%7.57M
68.77%-4.18M
46.42%-6.95M
33.03%-7.22M
7.03%-10.50M
17.27%-13.39M
3.14%-12.98M
43.96%-10.78M
39.99%-11.29M
17.16%-16.18M
Net Margin
----
-365.62%-77.95%
70.07%-111.54%
---348.39%
---1764.20%
--29.35%
---372.68%
----
----
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
----
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
-100.00%0.00
-43.24%1.02M
351.03%875.00K
--93.00K
--81.00K
--1.81M
--194.00K
----
----
--0.00
--0.00
----
----
-100.00%0.00
-100.00%0.00
-89.80%306.00K
1046.77%711.00K
300.75%533.00K
-13.00%348.00K
300.53%3.00M
Operating profit
-120.25%-3.21M
-266.93%-838.00K
10.82%-1.01M
-20.81%-1.67M
9.95%-1.46M
127.97%502.00K
58.39%-1.13M
25.79%-1.38M
50.60%-1.62M
59.71%-1.79M
40.00%-2.71M
86.12%-1.86M
74.78%-3.27M
68.93%-4.46M
59.96%-4.52M
12.17%-13.43M
3.07%-12.98M
25.42%-14.34M
47.11%-11.29M
23.03%-15.29M
Net Profit
-122.32%-3.18M
-250.75%-799.00K
-34.99%-976.00K
75.49%-324.00K
7.33%-1.43M
131.29%530.00K
-109.56%-723.00K
68.38%-1.32M
77.83%-1.54M
76.52%-1.69M
172.08%7.57M
68.77%-4.18M
46.42%-6.95M
33.03%-7.22M
7.03%-10.50M
17.27%-13.39M
3.14%-12.98M
43.96%-10.78M
39.99%-11.29M
17.16%-16.18M
Current assets
-31.31%3.09M
9.70%4.63M
42.76%5.07M
-14.74%4.02M
-25.22%4.50M
-47.35%4.22M
-64.03%3.55M
-33.71%4.71M
-27.85%6.01M
-45.86%8.02M
-54.45%9.86M
-77.55%7.11M
-80.54%8.34M
-73.28%14.82M
-65.99%21.66M
-56.60%31.68M
-3.62%42.84M
-5.20%55.46M
-9.19%63.68M
22.54%72.99M
Total current liabilities
60.64%1.71M
24.14%900.00K
25.29%877.00K
-37.60%800.00K
-25.95%1.07M
-65.24%725.00K
-70.10%700.00K
-74.09%1.28M
-80.87%1.44M
-72.65%2.09M
-72.55%2.34M
-49.79%4.95M
-20.65%7.53M
-31.20%7.63M
-24.89%8.53M
-6.26%9.85M
-29.52%9.49M
-34.61%11.09M
-30.17%11.36M
-32.82%10.51M
Total assets
-13.63%8.51M
4.28%9.98M
17.05%10.41M
-6.91%9.37M
-13.35%9.85M
-28.41%9.57M
-41.51%8.90M
-0.32%10.06M
-0.80%11.36M
-26.02%13.37M
-39.27%15.21M
-71.33%10.10M
-75.38%11.46M
-69.53%18.08M
-63.02%25.05M
-53.50%35.21M
-53.46%46.52M
-48.58%59.33M
-48.45%67.74M
-40.85%75.73M
Total liabilities
60.64%1.71M
24.14%900.00K
25.29%877.00K
-37.60%800.00K
-25.95%1.07M
-65.24%725.00K
-70.10%700.00K
-74.09%1.28M
-80.87%1.44M
-72.65%2.09M
-72.55%2.34M
-49.79%4.95M
-20.65%7.53M
-31.20%7.63M
-24.89%8.53M
-6.26%9.85M
-81.58%9.49M
-80.16%11.09M
-79.74%11.36M
-83.03%10.51M
Total equity
-22.65%6.79M
2.66%9.09M
16.35%9.54M
-2.43%8.57M
-11.52%8.78M
-21.60%8.85M
-36.32%8.20M
70.54%8.78M
152.82%9.92M
8.00%11.29M
-22.10%12.87M
-79.69%5.15M
-89.40%3.92M
-78.34%10.45M
-70.70%16.52M
-61.12%25.36M
-23.54%37.03M
-18.90%48.25M
-25.17%56.39M
-1.33%65.22M
Net operating income
-21.49%-1.18M
-538.61%-1.58M
84.62%-264.00K
54.52%-503.00K
48.26%-968.00K
123.36%360.00K
75.26%-1.72M
83.13%-1.11M
69.89%-1.87M
78.12%-1.54M
30.06%-6.94M
39.41%-6.55M
51.59%-6.21M
18.39%-7.04M
-25.14%-9.91M
-96.37%-10.82M
11.21%-12.84M
38.54%-8.63M
47.35%-7.92M
61.26%-5.51M
Net investment
---66.00K
----
----
----
----
--0.00
-100.00%0.00
----
----
--0.00
--10.40M
----
----
--0.00
100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-333.33%-7.00K
103.08%2.00K
Net financing
-40.00%825.00K
--251.00K
--1.83M
---130.00K
--1.38M
--0.00
--0.00
----
----
-100.00%0.00
--0.00
29452.94%5.02M
----
-85.88%12.00K
-100.00%0.00
-99.94%17.00K
-100.00%0.00
-46.54%85.00K
-99.82%43.00K
736.20%30.63M

FAQs

What is the total revenue of Cyclerion Therapeutics Inc?

According to Cyclerion Therapeutics Inc's FY2025 earnings report, its total revenue reached 2.07M, with a year-on-year change of 2.00M.

What are the current assets of Cyclerion Therapeutics Inc?

According to Cyclerion Therapeutics Inc's FY2025 earnings report, its current assets were 4.63M, with a year-on-year change of 9.70.

What are the total assets of Cyclerion Therapeutics Inc?

According to Cyclerion Therapeutics Inc's FY2025 earnings report, its total assets of Cyclerion Therapeutics Inc were 9.98M, with a year-on-year change of 4.28.

What are the total liabilities of Cyclerion Therapeutics Inc?

According to Cyclerion Therapeutics Inc's FY2025 earnings report, its total liabilities of Cyclerion Therapeutics Inc were 900.00K, with a year-on-year change of 24.14.

What is the total equity of Cyclerion Therapeutics Inc?

According to Cyclerion Therapeutics Inc's FY2025 earnings report, its total equity of Cyclerion Therapeutics Inc was 9.09M, with a year-on-year change of 2.66.

What is the net operating income of Cyclerion Therapeutics Inc?

According to Cyclerion Therapeutics Inc's FY2025 earnings report, its net operating income of Cyclerion Therapeutics Inc was -4.97M, with a year-on-year change of -37.07.

What is the Earnings Per Share (EPS) of Cyclerion Therapeutics Inc?

According to Cyclerion Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.11, with a year-on-year change of 8.65.

What is the net income of Cyclerion Therapeutics Inc?

According to Cyclerion Therapeutics Inc's FY2025 earnings report, its net income was -3.53M, with a year-on-year change of -15.41.

What is the net margin of Cyclerion Therapeutics Inc?

According to Cyclerion Therapeutics Inc's FY2025 earnings report, its net profit margin was -170.11, with a year-on-year change of -11.29.

What is the Return on Equity (ROE) of Cyclerion Therapeutics Inc?

According to Cyclerion Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -39.34, with a year-on-year change of -29.58.

What is the Return on Assets (ROA) of Cyclerion Therapeutics Inc?

According to Cyclerion Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -36.07, with a year-on-year change of -35.40.

What is the operating profit of Cyclerion Therapeutics Inc?

According to Cyclerion Therapeutics Inc's FY2025 earnings report, its operating profit was -4.97M, with a year-on-year change of -37.07.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.